Literature DB >> 27928299

Early Intraocular Complications of Subarachnoid Haemorrhage after Aneurysm Rupture.

Iwona Obuchowska1, Grzegorz Turek2, Zenon Mariak2, Zofia Mariak1.   

Abstract

The aim of this study was to identify factors predisposing for early intraocular complications of aneurysmal subarachnoid haemorrhage (SAH). The authors analysed 96 selected cases of aneurysmal SAH. Forty patients (42%) demonstrated abnormal fundus findings, including disc swelling (13.5%), retinal haemorrhages (23%), and vitreous haemorrhage (5%). The incidence of intraocular pathologies was significantly higher in patients who lost consciousness at the onset of SAH, were admitted with high scores of the Hunt-Hess and Fisher scales and low score of the Glasgow Coma Scale, as well as in those with arterial hypertension, more sizable aneurysm, and older.

Entities:  

Keywords:  Optic disc swelling; Terson syndrome; retinal haemorrhages; subarachnoid haemorrhage

Year:  2014        PMID: 27928299      PMCID: PMC5122976          DOI: 10.3109/01658107.2014.911918

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  17 in total

1.  Frequency of ocular hemorrhages in patients with subarachnoidal hemorrhage.

Authors:  T Ness; P Janknecht; C Berghorn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-15       Impact factor: 3.117

2.  Screening for ocular hemorrhages in patients with ruptured cerebral aneurysms: a prospective study of 99 patients.

Authors:  R T Frizzell; F Kuhn; R Morris; C Quinn; W S Fisher
Journal:  Neurosurgery       Date:  1997-09       Impact factor: 4.654

3.  Symptoms and signs of intracranial aneurysms with particular reference to retinal haemorrhage.

Authors:  J A Fahmy
Journal:  Acta Ophthalmol (Copenh)       Date:  1972

4.  Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage.

Authors:  F Kuhn; R Morris; C D Witherspoon; V Mester
Journal:  Ophthalmology       Date:  1998-03       Impact factor: 12.079

5.  Terson's syndrome in spontaneous subarachnoid hemorrhage: a prospective study in 60 consecutive patients.

Authors:  B Pfausler; R Belcl; R Metzler; I Mohsenipour; E Schmutzhard
Journal:  J Neurosurg       Date:  1996-09       Impact factor: 5.115

6.  Terson syndrome: a case report suggesting the mechanism of vitreous hemorrhage.

Authors:  T Ogawa; T Kitaoka; Y Dake; T Amemiya
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

7.  The natural history of nontraumatic subarachnoid hemorrhage-related intraocular hemorrhages.

Authors:  Hadas Stiebel-Kalish; Lawrence S Turtel; Mark J Kupersmith
Journal:  Retina       Date:  2004-02       Impact factor: 4.256

8.  Incidence of Terson's syndrome in patients with SAH in a Chinese hospital.

Authors:  Li Na Wu; Tao He; Yi Qiao Xing; Yin Shen
Journal:  Curr Eye Res       Date:  2012-08-22       Impact factor: 2.424

9.  [Incidence and relative factors of Terson syndrome in patients with aneurysmal subarachnoid hemorrhage].

Authors:  Tao He; Li-Na Wu; Bin Chen; Yi-qiao Xing
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2011-12

Review 10.  A systematic review of Terson's syndrome: frequency and prognosis after subarachnoid haemorrhage.

Authors:  M O McCarron; M J Alberts; P McCarron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

View more
  2 in total

1.  Vasoconstriction and Impairment of Neurovascular Coupling after Subarachnoid Hemorrhage: a Descriptive Analysis of Retinal Changes.

Authors:  Catharina Conzen; Walid Albanna; Miriam Weiss; David Kürten; Walthard Vilser; Konstantin Kotliar; Charlotte Zäske; Hans Clusmann; Gerrit Alexander Schubert
Journal:  Transl Stroke Res       Date:  2017-11-08       Impact factor: 6.829

2.  Clinical Study on Complications of Intracranial Ruptured Aneurysm Embolization by Stent-Assisted Coil.

Authors:  Yinlong Liu; Jianren Wang; Liqing Lin; Chunsheng Sang; Zexi Lin; Yaohua Pan; Xi'an Fu
Journal:  Med Sci Monit       Date:  2018-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.